Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, New York, USA.
Global Health. 2010 Nov 19;6:22. doi: 10.1186/1744-8603-6-22.
Nicotine replacement therapies (NRT) are powerful tools for the successful treatment of nicotine addiction and tobacco use. The medicines are clinically effective, supported by the Framework Convention on Tobacco Control, and are now World Health Organization-approved essential medicines. Enabling global access to NRT remains a challenge given ongoing confusion and misperceptions about their efficacy, cost-effectiveness, and availability with respect to other tobacco control and public health opportunities. In this commentary, we review existing evidence and guidelines to make the case for global access to NRT highlighting the smoker's right to access treatment to sensibly address nicotine addiction.
尼古丁替代疗法 (NRT) 是成功治疗尼古丁成瘾和烟草使用的有力工具。这些药物具有临床疗效，得到了《烟草控制框架公约》的支持，并且现在已被世界卫生组织批准为基本药物。尽管《烟草控制框架公约》和其他烟草控制及公共卫生机会都认可了 NRT 的有效性、成本效益，但是由于人们对其疗效、成本效益以及可及性仍然存在混淆和误解，因此全球范围内获得 NRT 仍然是一个挑战。在这篇评论中，我们回顾了现有证据和指南，以支持全球范围内获得 NRT，强调吸烟者有权获得治疗，以合理应对尼古丁成瘾。
